CN Patent

CN101129366A — 一种尼莫地平药物组合物及其制备方法

Assigned to Beijing Zhonghaikang Medical Technology Development Co Ltd · Expires 2008-02-27 · 18y expired

What this patent protects

本发明公开了一种新的尼莫地平药物组合物及其制备方法，它是由治疗有效量的尼莫地平、山梨醇或失水山梨醇脂肪酸单脂类表面活性剂、尼莫地平的良性溶剂、辅助增溶剂和注射用水组成的可制成注射剂或口服剂的浓溶液。本发明制备的浓溶液具有浓度大、稳定性好、辅料低、制备工艺简单等特点，可注射或口服用于治疗因蛛网膜下腔出血所引起的脑血管痉挛造成的脑组织缺血性损害。

USPTO Abstract

本发明公开了一种新的尼莫地平药物组合物及其制备方法，它是由治疗有效量的尼莫地平、山梨醇或失水山梨醇脂肪酸单脂类表面活性剂、尼莫地平的良性溶剂、辅助增溶剂和注射用水组成的可制成注射剂或口服剂的浓溶液。本发明制备的浓溶液具有浓度大、稳定性好、辅料低、制备工艺简单等特点，可注射或口服用于治疗因蛛网膜下腔出血所引起的脑血管痉挛造成的脑组织缺血性损害。

Drugs covered by this patent

Patent Metadata

Patent number
CN101129366A
Jurisdiction
CN
Classification
—
Expires
2008-02-27
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Zhonghaikang Medical Technology Development Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.